Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine in Pediatric Cancer Surgery
NCT03996655Phase 4Unknown
- Sponsor
- National Cancer Institute
- Start
- Jun 2019
- Primary completion
- Sep 2019
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 4 trial of Sugammadex in Postoperative residual curarization (PORC), sponsored by National Cancer Institute. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
Postoperative residual curarization (PORC)
Beyond the preview
Go deeper on NCT03996655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996655.